Leonardo Ferro Tavares

Leonardo Ferro Tavares

Auto-generated profile, based on publicly available information

Leonardo Ferro Tavares

Universidade Estadual Paulista (UNESP), School of Pharmaceutical Sciences, Department of Bioprocess Engineering and Biotechnology

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2021 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
VZVitória Fernanda Bertolazzi Zocca
Vitória Fernanda Bertolazzi Zocca
GCGraciely Gomes Corrêa
Graciely Gomes Corrêa
MLMilca Rachel da Costa Ribeiro Lins
Milca Rachel da Costa Ribeiro Lins
VJVictor Nunes de Jesus
Victor Nunes de Jesus
LTLeonardo Ferro Tavares
Leonardo Ferro Tavares
DPDanielle Pedrolli
Danielle Pedrolli
CRISPR has revolutionized the way we engineer genomes. Its simplicity and modularity have enabled the development of a great number of tools to edit genomes and to control gene expression. This powerful technology was first adapted to Bacillus subtilis in 2016 and has been intensely upgraded since then. Many tools have been successfully developed to build a CRISPR toolbox for this Gram-positive model and important industrial chassis. The toolbox includes tools, such as double-strand and single-strand cutting CRISPR for point mutation, gene insertion, and gene deletion up to 38 kb. Moreover, catalytic dead Cas proteins have been used for base editing, as well as for the control of gene expression (CRISPRi and CRISPRa). Many of these tools have been used for multiplex CRISPR with the most successful one targeting up to six loci simultaneously for point mutation. However, tools for efficient multiplex CRISPR for other functionalities are still missing in the toolbox. CRISPR engineering has already resulted in efficient protein and metabolite-producing strains, demonstrating its great potential. In this review, we cover all the important additions made to the B. subtilis CRISPR toolbox since 2016, and strain developments fomented by the technology. Graphical abstract

6 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
LTLeonardo Ferro Tavares
Leonardo Ferro Tavares
NRNathan Vinicius Ribeiro
Nathan Vinicius Ribeiro
VZVitória Fernanda Bertolazzi Zocca
Vitória Fernanda Bertolazzi Zocca
GCGraciely Gomes Corrêa
Graciely Gomes Corrêa
LALaura Araujo da Silva Amorim
Laura Araujo da Silva Amorim
DPDanielle Pedrolli
Danielle Pedrolli
A proper balance of metabolic pathways is crucial for engineering microbial strains that can efficiently produce biochemicals at an industrial scale while maintaining cell fitness. High production loads can negatively impact cell fitness and hinder industrial-scale production. To address this, fine-tuning of gene expression using engineered promoters and genetic circuits can promote control over multiple targets in pathways and reduce the burden. We took advantage of the robust carbon catabolite repression system of Bacillus subtilis to engineer a glucose-inducible genetic circuit that supports growth and production. By simulating cultivation scale-up under repressive conditions, we preserved the production capacity of cells, which could be fully accessed by switching to glucose in the final production step. The circuit is also resilient, enabling a quick switch in the metabolic status of the culture. Furthermore, the simulated scale-up process selected best-growing cells without compromising their production capability, leading to higher product formation at the end of the process. As a pathwayindependent circuit activated by the preferred carbon source, our engineered glucose-inducible genetic circuit is broadly useful and imposes not additional cost to traditional production processes.